Category Pharma/Biotech

Future Pak Proposes Acquisition of Theratechnologies Inc. in Deal Worth Up to $255 Million

Future Pak, LLC (“Future Pak”), a Michigan-based pharmaceutical packaging and manufacturing company, has officially announced the submission of two formal acquisition proposals to Theratechnologies Inc. (“Theratechnologies”), a biopharmaceutical company listed…

Read MoreFuture Pak Proposes Acquisition of Theratechnologies Inc. in Deal Worth Up to $255 Million

Sentynl Therapeutics Unveils First Clinical Evidence Supporting NULIBRY® for Molybdenum Cofactor Deficiency Type A

Sentynl Therapeutics Unveils First Clinical Evidence Supporting NULIBRY® for Molybdenum Cofactor Deficiency Type A Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly owned by Zydus Lifesciences, Ltd., has announced the…

Read MoreSentynl Therapeutics Unveils First Clinical Evidence Supporting NULIBRY® for Molybdenum Cofactor Deficiency Type A

Johnson & Johnson Completes Intra-Cellular Therapies Acquisition to Strengthen Neuroscience Leadership

Johnson & Johnson Completes Intra-Cellular Therapies Acquisition to Strengthen Neuroscience Leadership Johnson & Johnson (NYSE: JNJ) has officially completed its acquisition of Intra-Cellular Therapies, Inc., further strengthening its position in…

Read MoreJohnson & Johnson Completes Intra-Cellular Therapies Acquisition to Strengthen Neuroscience Leadership